Price T Rowe Associates Inc Axonics, Inc. Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Axonics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 31,286 shares of AXNX stock, worth $2.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

31,286

Previous 30,883 1.3%

Holding current value

$2.22 Million

Previous $2.08 Million 4.86%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$67.3 - $69.67 $27,121 - $28,077	403 Added 1.3%	31,286 $2.18 Million
Q2 2024 Aug 14, 2024	BUY	$66.47 - $69.65 $132,009 - $138,324	1,986 Added 6.87%	30,883 $2.08 Million
Q1 2024 May 15, 2024	BUY	$56.67 - $69.36 $103,592 - $126,790	1,828 Added 6.75%	28,897 $1.99 Million
Q4 2023 Feb 14, 2024	BUY	$49.38 - $63.75 $69,922 - $90,270	1,416 Added 5.52%	27,069 $1.69 Million
Q3 2023 Nov 14, 2023	BUY	$48.64 - $62.51 $56,714 - $72,886	1,166 Added 4.76%	25,653 $1.44 Million
Q2 2023 Aug 14, 2023	BUY	$47.99 - $60.21 $86,573 - $108,618	1,804 Added 7.95%	24,487 $1.24 Million
Q1 2023 May 15, 2023	BUY	$52.6 - $67.34 $39,765 - $50,909	756 Added 3.45%	22,683 $1.24 Million
Q4 2022 Feb 14, 2023	BUY	$59.56 - $76.6 $40,262 - $51,781	676 Added 3.18%	21,927 $1.37 Million
Q3 2022 Nov 14, 2022	BUY	$57.96 - $78.12 $601,914 - $811,276	10,385 Added 95.57%	21,251 $1.5 Million
Q2 2022 Aug 15, 2022	BUY	$39.5 - $64.42 $12,877 - $21,000	326 Added 3.09%	10,866 $616,000
Q1 2022 May 16, 2022	SELL	$43.74 - $62.76 $834,865 - $1.2 Million	-19,087 Reduced 64.42%	10,540 $660,000
Q4 2021 Feb 14, 2022	SELL	$50.01 - $73.35 $19.9 Million - $29.2 Million	-398,493 Reduced 93.08%	29,627 $1.66 Million
Q3 2021 Nov 15, 2021	SELL	$59.21 - $78.66 $191,425 - $254,307	-3,233 Reduced 0.75%	428,120 $27.9 Million
Q2 2021 Aug 16, 2021	SELL	$51.39 - $66.9 $1.5 Million - $1.95 Million	-29,111 Reduced 6.32%	431,353 $27.4 Million
Q1 2021 May 17, 2021	SELL	$49.14 - $59.89 $111,449 - $135,830	-2,268 Reduced 0.49%	460,464 $27.6 Million
Q4 2020 Feb 16, 2021	BUY	$42.19 - $51.5 $19.5 Million - $23.8 Million	462,732 New	462,732 $23.1 Million

Others Institutions Holding AXNX

# of Institutions

234

Shares Held

42.1M

Call Options Held

83.4K

Put Options Held

65.3K

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Axonics, Inc. Transaction History